Nubeqa (Darolutamide)
Nubeqa (Darolutamide)
Nubeqa (Darolutamide) is a prescription medication specifically designed to treat men with non-metastatic castration-resistant prostate cancer (nmCRPC). As an androgen receptor inhibitor, Nubeqa helps block the effects of androgens (male hormones) that can fuel cancer growth, helping to delay the progression of prostate cancer in men whose disease has not yet spread to other parts of the body.
Why Choose Nubeqa (Darolutamide)?
- Delay in Cancer Progression: Proven to help slow the progression of nmCRPC, providing more time before cancer spreads.
- Convenient Oral Treatment: Easy-to-take tablet form that fits into daily routines.
- Effective in Combination: Works alongside androgen deprivation therapy (ADT) to enhance treatment efficacy.
- Improved Survival Rates: Shown in clinical studies to extend survival and improve quality of life for men with nmCRPC.
How to Use Nubeqa (Darolutamide)?
- Follow Prescription Guidelines: Take Nubeqa as directed by your healthcare provider, typically twice daily with food.
- Do Not Alter Dosage: Avoid changing the dosage unless instructed by a healthcare professional.
- Continue Androgen Deprivation Therapy (ADT): Nubeqa should be taken alongside ADT, as it is most effective in combination.
- Avoid Missing Doses: Take Nubeqa at the same time each day to maintain steady levels of the medication.
- Inform Healthcare Providers of Other Medications: Consult your healthcare provider about any other medications or supplements, as Nubeqa may interact with certain drugs.
Important Safety Information about Nubeqa
- Pre-existing Conditions: Inform your doctor if you have a history of liver, kidney, or cardiovascular disease.
- Interactions with Other Medications: Nubeqa can interact with certain medications, so disclose all medications you’re currently taking.
- Regular Monitoring: Your healthcare provider may need to monitor blood tests and assess liver function throughout your treatment.
- Pregnancy and Breastfeeding: Nubeqa is not indicated for use in women. Women who are pregnant or may become pregnant should avoid handling Nubeqa tablets.
Fact Table for Nubeqa
Facts | Details |
Generic Name | Darolutamide |
Brand Name | Nubeqa |
Drug Class | Androgen Receptor Inhibitor |
Indication | Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) |
Administration | Oral tablet |
Dosage Form | 300 mg tablets |
Typical Dosage | 600 mg (two 300 mg tablets) taken twice daily with food |
Mechanism of Action | Inhibits androgen receptors to prevent male hormones from stimulating cancer cell growth |
Key Benefits | Delays progression of nmCRPC, easy oral administration, effective with ADT, improves survival rates |
Common Side Effects | Fatigue, pain in extremities, rash, decreased appetite |
Special Precautions | Monitor liver function and blood pressure regularly, consult a physician about drug interactions, not suitable for pregnant or breastfeeding individuals |
Use in Combination With | Androgen Deprivation Therapy (ADT) |
Storage Conditions | Store at room temperature (20-25°C or 68-77°F); protect from moisture |
Approval Status | Approved by the FDA for treatment of non-metastatic castration-resistant prostate cancer |
Common Side Effects of Nubeqa
Like all medications, Nubeqa (Darolutamide) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.
- Fatigue
- Muscle or joint pain, particularly in the arms or legs
- Rash
- Decreased Appetite
If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.
How Can You Buy Nubeqa (Darolutamide)?
You can order Nubeqa (Darolutamide) using these methods on our website:
- Order Online
- Order by Phone
- Order by Fax
- Order your refills
Visit our How to order page.